Mevion Medical Systems is pleased to announce the promotion of Lionel Bouchet, Ph.D., to Senior Vice President of Commercial Development, North America, effective January 18. A 15-year veteran of Mevion, Lionel’s knowledge, industry experience, and strong relationships with our colleagues, customers, and the radiation oncology community position him exceptionally well to lead Mevion’s commercial team. We congratulate him and look forward to his continued leadership.
James Meng, Ph.D., President of Mevion, has decided to resign due to family priorities, effective January 31. James has been an integral member of our executive leadership team over the past four years. Mevion has benefitted greatly from his leadership during his tenure. While Mevion will miss his guidance, we recognize the importance of family, and thank him for his valuable contributions, and wish him the best as he moves forward. Tina Yu, PhD., CEO of Mevion, will absorb the role of President and will work closely with the commercial team to further advance Mevion’s success.
Source: Mevion Medical Systems.